UNSPSC 51361901: Butabarbital
Commodity
Code facts
- Part of
-
-
51000000
-
51360000
- 51361900
-
51360000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51361901
Definition
This classification denotes a barbiturate with the molecular formula C10H16N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P0078O25A9, chemically known as 2,4,6(1h,3h,5h)-pyrimidinetrione, 5-ethyl-5-(1-methylpropyl)- but generally known as butabarbital, which bears US NIH Compound Identifier 2479. Butabarbital most often comes in base and hydrochloride forms. European Medicines Agency schedules Secbutabarbital in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10465MIG.
Read the full definition
The term SECBUTABARBITAL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). Most nations schedule butabarbital under HS 29335300 and SITC 51576. As of Q4 2014, BUTABARBITAL remains the US FDA Preferred Term for this commodity. Butabarbital bears US NLM identifiers UMLS ID C0006464 and NCI Concept Code C61657. SMILES: CCC(C)C1(C(=O)NC(=O)NC1=O)CC.
About UNSPSC 51361901
UNSPSC 51361901 Butabarbital is a Commodity code for a specific pharmaceutical product, but state and local government procurement activity under this code does not align with the code's nominal scope. The recent opportunities tagged to this code show demand for naloxone (an opioid antagonist), direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and over-the-counter products — none of which are butabarbital, a barbiturate sedative. The mismatch suggests either that the code is being misapplied in the source data or that this specific commodity sees minimal direct procurement activity in the state and local market.
The three opportunities identified span different jurisdictions and procurement mechanisms: Seminole County, Florida issued an IFB for naloxone and drug deactivation systems (1,900 units of naloxone and 800 deactivation systems annually, due July 26, 2023); the Texas Health and Human Services Commission posted an RFI on April 3, 2026 to explore capabilities for a direct-to-manufacturer pharmacy program; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response deadline, administered through authorized wholesalers (AmerisourceBergen, Cardinal Health, and Morris & Dickson). These examples reflect broader state and local pharmacy procurement patterns centered on managed access, cost control, and multi-jurisdiction cooperative purchasing, rather than procurement of butabarbital specifically. The code as tagged shows no current relevant activity for this commodity.
Quick answers
What is UNSPSC 51361901?
UNSPSC 51361901 is Butabarbital, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51361901?
UNSPSC 51361901 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).
On GovTribe
See everything under UNSPSC 51361901
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code